Description
Pamidronate disodium is a bisphosphonate medication indicated to treat osteoporosis, high calcium levels during cancer, Paget’s disease, and bone metastases. All of these conditions are disorders of the bone, and pamidronate helps to restore normal bone health.
Pamidronate works by attaching to calcium phosphate crystals in the bone. By Incorporating into calcium phosphate, pamidronate prevents bone recycling and helps maintain bone health. Pamidronate also prevents the activity of osteoclasts, which are bone cells that become too active during cancer.
Fact Table |
Formula |
C3H9NNa2O7P2 |
License |
US FDA |
Bioavailability |
N/A (administered intravenously) |
Legal status |
Prescription only (?) |
Chemical Name |
Disodium 3-amino-1-hydroxypropylidene-1,1-bisphosphonate |
Elimination half-life |
28.3 hours |
Dosage (Strength) |
30 mg, 60 mg, 90 mg vials for injection |
Pregnancy |
Consult a doctor |
Brands |
Aredia, Pamimed |
Protein binding |
54% |
PubChem CID |
46721 |
MedlinePlus |
a601163 |
ChEBI |
CHEBI:29353 |
ATC code |
M05BA03 |
DrugBank |
DB00282 |
KEGG |
D00451 |
Routes of administration |
Intravenous |
Directions
Pamidronate disodium should only be administered by a trained healthcare professional via intravenous infusion. It is usually administered in an infusion clinic.
Your dosage will depend on the condition being treated. Take pamidronate exactly as directed by your doctor.
The maximum dosage of pamidronate per infusion is 90 mg.
Treatment should not occur more frequently than every seven days.
Your doctor may have you take calcium and vitamin D supplements between infusions.
Ingredients
The active ingredient in pamidronate is pamidronate disodium.
The inactive ingredients are mannitol and phosphoric acid.
Interactions
There are no significant drug-drug interactions between pamidronate and other medications.
Cautions
Your doctor should monitor your calcium, phosphate, magnesium, and potassium levels before and during therapy.
Tell your doctor if you have a history of thyroid problems.
Use caution if you have a history of kidney disease before starting pamidronate. This drug is removed from the body via the kidneys, so it can accumulate to dangerous levels in people with kidney disease.
See a dentist regularly while taking pamidronate to assess for jaw osteonecrosis.
Do not take pamidronate if you are pregnant or planning to become pregnant.
Side Effects
Common side effects of this drug may include:
- Anemia
- Arthralgia
- Bone pain
- Cough
- Deteriorating renal function
- Dyspnea
- Fatigue
- Focal segmental glomerulosclerosis
- Hypocalcemia
- Hypokalemia
- Hypertension
- Hypomagnesemia
- Hypophosphatemia
- Injection site disorder
- Loss of appetite
- Malaise
- Myalgia
- Nausea
- Nephrotoxicity
- Osteonecrosis of jaw
- Seizure
- Urinary tract infectious disease
- Vomiting
References
- Pamidronate [package insert]. Bedford, OH: Bedford Laboratories; January 2009.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14579